Does it bother anyone else when you are doing a list of abbreviations but you cannot find the representation for some letters? Thankfully there is QSAR for Q, but the J is always the true challenge.

A peer-reviewed playlist for moving furniture open.spotify.com/playlist/7xHRd…

MUG: A mutation overview of GPCR subfamily A17 receptors sciencedirect.com/science/articl… #gpcr #bioinformatics #computationalbiology #Mutant #structure #neuroscience

Today on the blog: founder Viswa Colluru  lays out how re-integrating chemistry into our understanding of cell & organismal biology can complement and extend our genomically-inspired map of biology -- and the tech Enveda is building to make this happen: enveda.com/posts/the-chem…

Join us Thursday, Jan 11 at the main stage of #JPM24 as Founder & CEO Viswa Colluru presents exciting new preclinical data comparing Enveda's lead asset to blockbuster anti-inflammatory therapies, plus pipeline and platform updates. Don't miss it!

new: "POSEIDON: Peptidic Objects SEquence-based Interaction with cellular DOmaiNs: a new database and predictor" jcheminf.biomedcentral.com/articles/10.11…

Multi-omics data integration identifies novel biomarkers and patient subgroups in inflammatory bowel disease medrxiv.org/cgi/content/sh… #medRxiv

This one is special… We have advanced our first drug into Phase 1 clinical trials! ENV-294 is a first-in-class small molecule with exciting potential to treat atopic dermatitis (commonly known as eczema) – an underserved and devastating inflammatory condition that impacts more

How we built a unicorn from seed in 5 years… There are no secrets, but purpose, pace, and an incredible team certainly help. “We’re combining ancient ancestral wisdom with the power of nature’s chemistry with modern AI and drug discovery,” Colluru said. “We’re standing on the